BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2814948)

  • 21. Evaluation of antithrombin-III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection.
    Boudreaux MK; Weiss RC; Cox N; Spano JS
    Am J Vet Res; 1989 Nov; 50(11):1910-3. PubMed ID: 2559630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.
    Preusser P; Pielken HJ; Bauch HJ
    Haematol Blood Transfus; 1987; 30():288-92. PubMed ID: 3476359
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical observations of 30 patients with acute promyelocytic leukemia].
    Chang CS; Chen JR; Lin SF; Liu HW; Yen JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Oct; 2(10):608-15. PubMed ID: 3330141
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes of prekallikrein in the cases with disseminated intravascular coagulation syndrome.
    Sakuragawa N; Takahashi K; Shibata A
    Adv Exp Med Biol; 1979; 120B():185-93. PubMed ID: 160191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention and early diagnosis of disseminated intravascular coagulation].
    Matsuda T
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J; Brüggener E; Markwardt F
    Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
    Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and intensive treatment of acute leukemia in pregnancy].
    Sierra J; Urbano Ispizua A; Cararach V; Carreras E; Fortuny A; Grañena A; Rozman C
    Med Clin (Barc); 1987 Jan; 88(1):28-31. PubMed ID: 3469488
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Types of AT III abnormalities and their significance in hypercoagulability.
    Nagy I; Losonczy H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):421-5. PubMed ID: 6083906
    [No Abstract]   [Full Text] [Related]  

  • 35. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
    Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
    Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia.
    Boughton BJ; Franklin IM; Apperley J; Knight D
    Br J Haematol; 1984 Oct; 58(2):378-80. PubMed ID: 6591946
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of acute myelocytic leukemia with a daunorubicin-cytarabine-6 thioguanine regimen without maintenance therapy.
    Freund M; Poliwoda H; Bodenstein H; Eisert R
    Onkologie; 1985 Jun; 8(3):150-2. PubMed ID: 3895097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
    Génova V; Georgief Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):300-12. PubMed ID: 4136341
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.
    Farah RA; Jalkh KS; Farhat HZ; Sayad PE; Kadri AM
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):140-3. PubMed ID: 21178585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.